Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Apotex Inc.
FDA Inspection
•Apotex Inc.•May 9, 2025

Apotex Inc. – FDA Inspection, May 9, 2025

Record Details

This FDA Inspection record concerns Apotex Inc., with an inspection on May 9, 2025, issued by the Office of Inspections and Investigations, covering human drugs.

Company
Apotex Inc.
Inspection Date
May 9, 2025
Product Type
Human Drugs
Office
Office of Inspections and Investigations
People
  • Justin A. Boyd (Investigator)
  • Wayne D. Mcgrath
View Company Profile

ID · 703c7656-f27a-4908-9f8d-7a38c7b5f345

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1269710
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued, view the record

FDA Citations

10
  1. 21 CFR 211.68(b)Computer control of master formula records
  2. 21 CFR 211.42(c)(10)(vi)Equipment to control conditions
  3. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  4. 21 CFR 211.160(a)Following/documenting laboratory controls
  5. 21 CFR 211.198(a)Complaint Handling Procedure
  6. 21 CFR 211.113(b)Procedures for sterile drug products
  7. 21 CFR 211.113(b)Validation lacking for sterile drug products
  8. 21 CFR 211.192Investigations of discrepancies, failures
  9. 21 CFR 211.110(a)Written in-process control procedures
  10. 21 CFR 211.100(a)Absence of Written Procedures

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Apotex Inc.

10
DateClassificationOfficeProject area
March 8, 2024NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
March 24, 2023NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
September 14, 2022VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
June 28, 2019NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
March 22, 2019NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
View all 10 other inspections on the company page
Other documents for Apotex Inc.
  • FDA Inspection 1231036 - 2024-03-08
  • FDA Inspection 1203170 - 2023-03-24
  • FDA Inspection 1179507 - 2022-09-14
  • FDA Inspection 1098988 - 2019-06-28
  • FDA Inspection 1086265 - 2019-03-22

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Apotex Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.